Replies to post #30360 on 22nd Century Group Inc (XXII)

[NKerf]

The article explicitly listed content as .6 and yield as .05, which is a consistent ratio of content to yield for a cigarette. If you read the science articles they publish or watch the youtube series on the testing of Quest (a similar product), you will see that this is clearly the case.

You can disagree all you want, but there has never been any mention of 2 types of Brand A, and it is completely inconsistent with the MRTP (its clearly stated as for only for one specific brand/type and not for the tech or tobacco). Considering this and how precisely they use the terms yield and content, there is absolutely no logical reason to believe they aren't talking about the same brand type.

A little due diligence and a lot of science/lab testing background goes a long way, people.....

[Boogins]

I'm sure there is only one product in front of the FDA, but let's not get distracted by this. The key is that XXII is ALONE in front of them, the FDA is clearly backing reducing nicotine as a central tenet in their public health policy. So the odds of getting the modified risk designation are very very good.

If you don't understand the significance of all this, it means that XXII will have a virtual monopoly in the 'modified risk' space. XXII's first product may well be followed by others, and they would have their own approval timeline, but having a 'reduced' label on a pack of cigarettes will be huge, as it will replace the old designations of 'light' or 'low _____' or whatever.

The 'light' market was a pretty robust market until it got quashed by the FDA. It could get rebuilt under XXII.